Arbe Robotics Ltd. (NASDAQ:ARBE – Get Rating) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $16.00.
Read more here.
![[Zebra in AIThority] Zebra Medical Vision Presents AI Solutions In Collaboration With Global Leaders Philips, Canon Medical Systems US, And Change Healthcare At RSNA](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
